Similarly, the group of biopsy-confirmed non-NASH patients incorrectly classified as NASH (false positive) had clinical profiles consistent with their NASHmap prediction, with mean values for HbA1C, AST, ALT, and total protein significantly increased as compared to correctly classified patients (true negatives). Here, GPT is linked to metabolic dysfunction-associated steatohepatitis.